No Trial Left Behind: Streamlining Clinical Trial Evidence for Systematic Review
When a clinical trial evaluates a novel drug or uncovers a change in medical best practices, the results are often published in a widely-read scientific journal, like JAMA, Lancet, or the NEJM. Even trials that don’t unveil the next blockbuster drug are vital. Trials showing no effect compared to placebo, so-called “negative” or inconclusive trials, […]
